Christine Clemson

Christine Clemson is a seasoned professional in the pharmaceutical and medical affairs industry, currently serving as the Senior Vice President, Head of Medical Affairs at Fulcrum Therapeutics, a role she assumed in August 2024. Prior to this, she held significant positions at Albireo Pharma, Inc., where she worked as the Senior Vice President, Global Head of Medical Affairs from January 2022 to March 2023, and as Vice President of Medical Affairs from November 2019 to January 2022.1

Educational Background

Christine Clemson holds a Bachelor of Science in Chemistry from William & Mary and advanced degrees from UMass Chan Medical School, including a Master of Science in Clinical Investigation and a Ph.D. in Cell Biology.1

Career Highlights

• Fulcrum Therapeutics: Senior Vice President, Head of Medical Affairs (August 2024 - Present)
• Albireo Pharma, Inc.: Senior Vice President, Global Head of Medical Affairs (January 2022 - March 2023); Vice President of Medical Affairs (November 2019 - January 2022)
• AMAG Pharmaceuticals: Vice President of Medical Affairs (January 2019 - November 2019)
• SAGE Therapeutics: Senior Medical Director (December 2016 - November 2019)

Christine's extensive experience spans various roles in medical affairs across multiple pharmaceutical companies, underscoring her expertise in the field.